The Pharmagellan Guide to Analyzing Biotech Clinical Trials is a comprehensive primer to help non-experts evaluate clinical studies of new therapies.
- Structured roadmap for assessing the main components of a planned or completed biotech trial.
- Clear explanations of the most common concepts and terms in clinical studies, illustrated with over 100 real-world examples.
- Deep dives on essential topics like P values, sample size calculations, and Kaplan-Meier curves, written in plain English for non-statisticians.
- Pointers for interpreting positive and negative results, understanding common figures and tables, and identifying red flags in press releases
- If you’re a biotech executive, investor, adviser, or entrepreneur — or aspire to be one — this handbook will give you the foundation you need to analyze clinical trials with more confidence.
